Search results
RSV Infection Raises Risk for Acute Cardiovascular Events
Medscape· 2 days agoAccording to a US cross-sectional study, every fifth hospital patient with a respiratory syncytial...
Is This a Setback for Moderna?
The Motley Fool via AOL· 3 days agoInvestors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it...
HSA approves new RSV vaccine – a breakthrough in elderly respiratory health
MSN News· 2 days agoSINGAPORE: Singapore’s Health Sciences Administration (HSA) has given the green light to the Arexvy...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 4 days agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
Does Medicare Cover the RSV Vaccine?
US News Health· 3 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 3 days ago(NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have ...
NanoViricides shares gain as new data shows lead drug asset's strong activity against RSV
Proactive Investors· 3 days agoNanoViricides (NYSE-A:NNVC) has released new data which shows the strength of the antiviral activity...
Company News For May 13, 2024
Zacks via Yahoo Finance· 4 days agoModerna, Inc. (MRNA) shares dropped 4.4% after the company announced that the Food and Drug Administration (FDA) postponed its approval decision for...
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral potential
Proactive Investors· 4 days agoNanoViricides (NYSE-A:NNVC) has released a slew of new data supporting the safety and ultra-broad...